5, Blossom St

Boston,

MA,

USA,

ZIP: 02114

Phone: +16174554188

The Fusion Protein Engineering and Developability Summit is the definitive event catering to drug developers with novel fusion protein pipelines - it is a conference not to be missed!

With rapid development in novel fusion protein pipelines fuelling the demand for practical, effective engineering techniques to accelerate developable drugs into the clinic, you simply can't miss out on this highly anticipated event. With leading experts from Roche, Merck, Bristol Myers Squibb, Abbvie and many more, this is a unique opportunity to connect with other drug developers, share innovative ideas and strategies, and gain valuable insights on cutting edge fusion application.

With 24+ speakers, 3 hands-on workshops, and 2 days of packed data-driven case studies, this is set to be the definitive event of the year and you cannot afford to miss it!

URLs:
Brochure: https://go.evvnt.com/1657169-0?pid=1052
Tickets: https://go.evvnt.com/1657169-1?pid=1052
LinkedIn: https://go.evvnt.com/1657169-4?pid=1052

Basil Golding, Office Director, FDA, Hilmar Ebersbach, SVP Antibody Development and Protein Engineering, Immunos Therapeutics, Medha Tomlinson, Director - Global Biologics Research, Takeda, Naresh Chennamsetty, Associate Scientific Director, Bristol Myers Squibb, Ramkrishna Sadhukhan, Head of Cell, Gene, and Protein Engineering, Biotherapeutics, AbbVie, Rosa Grenha, Principal Scientist - Molecular Discovery, Merck and Co, Abhinav Gupta, Senior Machine Learning Scientist, Sanofi, Christian Klein, Head of Cancer Immunotherapy Discovery Oncology Programs and Department, Roche, Daniel Serna, Principal Research Scientist, AbbVie, Even Walseng, Associate Director, AstraZeneca